Glaucoma and Marijuana: What the Research Shows
How Marijuana Affects Eye Pressure
Marijuana and its potential effects on eye pressure have been a topic of public interest for decades, especially among patients managing glaucoma. While early studies showed that cannabis can temporarily reduce intraocular pressure (IOP), the full picture is more nuanced than many people realize. At Greenwich Ophthalmology Associates, our glaucoma specialists in the greater NY/CT region help patients understand the science behind popular claims so they can make informed decisions about their eye health. This page walks through the current research on marijuana and glaucoma, explains why major eye care organizations advise against its use as a treatment, and outlines the proven alternatives available today.
Research dating back several decades has explored whether marijuana and its active compounds can lower the fluid pressure inside the eye. Understanding this research provides important context for patients who may have heard that cannabis helps with glaucoma.
Studies conducted in the 1970s first demonstrated that smoking marijuana lowered intraocular pressure in both healthy individuals and those with glaucoma. This early work, supported in part by the National Eye Institute, generated significant interest because conventional glaucoma medications at the time caused a range of uncomfortable side effects. Researchers found that some derivatives of marijuana reduced IOP when taken orally, intravenously, or by smoking, confirming that the effect was real and measurable.
The pressure-lowering effect of cannabis is primarily attributed to delta-9-tetrahydrocannabinol (THC), the main psychoactive compound in marijuana. Clinical studies have shown that THC can reduce IOP by roughly 15 to 30 percent, which is comparable to the reduction achieved by some single-agent prescription eye drops. However, this effect varies between individuals and depends on the method of consumption and dosage.
Researchers have attempted to develop THC-based eye drops to deliver the pressure-lowering benefit directly to the eye without causing systemic side effects. Unfortunately, these topical formulations have not been successful. THC is poorly soluble in water, making it difficult to formulate as an effective eye drop. Studies testing topical cannabis preparations found that they did not lower eye pressure and often caused significant burning and irritation.
Why Doctors Do Not Recommend Marijuana for Glaucoma
Despite the confirmed short-term effect on eye pressure, every major ophthalmology organization advises against using marijuana as a glaucoma treatment. Several important reasons support this position.
Glaucoma requires consistent, around-the-clock pressure control to protect the optic nerve from progressive damage. Marijuana's pressure-lowering effect typically peaks within 30 to 60 minutes and lasts only three to four hours. This means a patient would need to consume marijuana six to eight times per day, every day, to maintain any meaningful pressure reduction. This frequency is neither practical nor safe for long-term disease management.
One of the most significant concerns involves marijuana's effect on blood pressure throughout the body. While THC lowers intraocular pressure, it also lowers systemic blood pressure. Reduced blood pressure can decrease blood flow to the optic nerve, which is the very structure that glaucoma damages. Scientists believe this reduction in optic nerve blood supply could potentially cancel out any benefit from lower eye pressure and may even accelerate glaucoma progression in some patients.
No clinical trial has ever demonstrated that marijuana use alters the long-term course of glaucoma or prevents vision loss. While we know that marijuana can briefly lower pressure readings, there is no evidence that this translates into preserved optic nerve health or maintained visual field over months and years. Without this critical long-term data, recommending marijuana as a treatment would be medically unsound.
Duration of Marijuana's Pressure-Lowering Effect
Understanding the timeline of marijuana's effect on eye pressure helps explain why it falls short as a viable treatment compared to proven glaucoma medications.
When marijuana is smoked, the reduction in intraocular pressure begins within minutes and reaches its peak effect at approximately 30 to 60 minutes. After this peak, the pressure-lowering effect steadily diminishes and is generally gone within three to four hours. Oral consumption may shift the timing slightly, but the overall duration remains similarly limited. This transient effect stands in sharp contrast to modern glaucoma eye drops, many of which provide sustained pressure control with once- or twice-daily dosing.
Because glaucoma demands continuous pressure management, relying on marijuana would mean consuming it approximately every three to four hours, including during the night. This schedule would result in near-constant intoxication, making it impossible for most patients to work, drive, or carry out daily activities. The cognitive impairment and sedation associated with this level of marijuana use present serious safety and quality-of-life concerns that far outweigh any potential benefit to eye pressure.
Risks and Downsides of Using Marijuana for Glaucoma
Beyond the short duration and lack of long-term evidence, using marijuana for glaucoma carries several specific risks that patients should understand.
Marijuana use produces a wide range of effects throughout the body that go well beyond the eye. Common side effects include increased heart rate, impaired short-term memory, altered judgment, dizziness, and mood changes. Chronic use carries additional risks, including potential respiratory issues from smoking and the possibility of developing cannabis use disorder. These side effects are especially concerning for older adults, who make up the majority of glaucoma patients.
As noted, marijuana lowers blood pressure systemically. In the context of glaucoma, where the optic nerve is already vulnerable, any reduction in blood supply to this critical structure is worrisome. Research increasingly recognizes that poor optic nerve blood flow contributes to glaucoma damage independently of eye pressure. Using a substance that further compromises this blood flow could make the disease worse rather than better, even if pressure readings appear temporarily improved.
The level of marijuana consumption required to maintain a meaningful effect on eye pressure would leave patients in a perpetual state of intoxication. This would interfere with the ability to manage other aspects of daily life with glaucoma, including adhering to appointment schedules, driving to follow-up visits, and performing tasks that require clear thinking. For patients who are already adjusting to vision changes, adding cognitive impairment creates an unnecessary burden.
Patients using marijuana alongside prescription glaucoma treatments may experience unpredictable interactions. The blood-pressure-lowering effects of marijuana could compound similar effects from certain glaucoma eye drops such as beta-blockers, potentially leading to episodes of dizziness or fainting. Additionally, the inconsistent dosing inherent in marijuana use makes it difficult for our glaucoma specialists to accurately assess whether a patient's prescribed treatment plan is working effectively.
Frequently Asked Questions
Researchers continue to explore whether specific cannabinoid compounds can be isolated and formulated into effective, targeted eye medications. Early work has focused on synthetic cannabinoids and novel drug delivery systems that could potentially provide pressure-lowering benefits without the systemic side effects of smoking or ingesting marijuana. However, none of these experimental approaches have progressed to the point of clinical approval, and significant hurdles remain in achieving adequate drug concentration within the eye.
Standard glaucoma treatments are significantly more effective and practical than marijuana. Modern prescription eye drops can lower IOP by 20 to 35 percent with just one or two applications per day and maintain that reduction around the clock. Laser procedures such as selective laser trabeculoplasty can provide sustained pressure reduction for years. Surgical options, including minimally invasive glaucoma surgery, offer additional long-term control. All of these approaches come with well-documented safety profiles and decades of evidence showing they preserve vision, which marijuana lacks.
The American Academy of Ophthalmology does not recommend marijuana or other cannabis products for the treatment of glaucoma. Their position, shared by the American Glaucoma Society, is based on the short duration of marijuana's pressure-lowering effect, its significant side effects, its impact on blood pressure and optic nerve blood flow, and the absence of evidence that it changes the long-term course of the disease. Both organizations emphasize that proven, safe, and effective treatments already exist.
CBD (cannabidiol) does not appear to help with glaucoma and may actually be harmful. A notable 2018 study found that CBD increased eye pressure by approximately 18 percent in animal models, an effect that lasted at least four hours. Additionally, research has shown that CBD may interfere with and cancel out the pressure-lowering effects of THC. The American Academy of Ophthalmology specifically warns against using CBD for glaucoma. Patients using CBD products for other health reasons should inform our glaucoma specialists, as it could potentially affect their eye pressure readings.
Several states include glaucoma on their list of qualifying conditions for medical marijuana programs. However, this legal status does not reflect a medical endorsement of marijuana as an effective glaucoma therapy. These designations were often made based on the early research showing that marijuana can lower eye pressure, without fully accounting for the limitations that make it impractical for ongoing glaucoma care. Patients in states with such provisions should still follow the treatment recommendations of their ophthalmologist, who can offer therapies with proven long-term benefits.
If you use marijuana or CBD products for any reason, it is important to share this information with your eye care team. Cannabis use can temporarily affect eye pressure measurements, potentially complicating the accuracy of your glaucoma monitoring. Marijuana may also interact with certain prescribed eye medications or affect your systemic health in ways that influence treatment decisions. Being open about your use helps our team provide you with the most accurate assessments and tailor your treatment plan effectively. You may also want to explore how other lifestyle factors, such as caffeine consumption, may relate to your eye pressure.
Protecting Your Vision with Proven Glaucoma Care
While the idea of using marijuana for glaucoma may seem appealing, the research consistently shows that it is not a safe or effective substitute for established treatments. At Greenwich Ophthalmology Associates, our fellowship-trained glaucoma specialists work with patients throughout the greater NY/CT region to develop personalized treatment plans using therapies backed by decades of clinical evidence. If you have questions about your glaucoma management or want to discuss any aspect of your care, we welcome the opportunity to help you protect your vision for the long term.
We encourage you to bring your questions and concerns to your next appointment so we can develop a care plan that addresses your goals and lifestyle.
Learn More About Related Topics
To further your understanding, explore our resources on Glaucoma and Coffee: Latest Research, Glaucoma and Marijuana: Does It Help?, and Pigmentary Glaucoma and Pseudoexfoliation Glaucoma.
You may also find these pages helpful: Angle-Closure Glaucoma: Recognizing the Emergency, Angle-Closure Glaucoma: Symptoms & Emergency Treatment, and Brimonidine Eye Drops for Glaucoma.
What our Patients say
4.8
Reviews
(3,408)